A low prevalance of purified protein derivative test positivity in Turkish patients with rheumatoid arthritis. Association with clinical features and HRCT findings
- PMID: 17417991
A low prevalance of purified protein derivative test positivity in Turkish patients with rheumatoid arthritis. Association with clinical features and HRCT findings
Abstract
Objectives: In this study, we aimed to evaluate the frequency of purified protein derivative (PPD) skin test positivity and associated clinical features in RA patients.
Materials and methods: We included 94 (80 F, 14 M, mean age: 55.8) consecutive RA patients with a disease duration of 8.7 years. PPD test was performed in all RA patients; clinical features were recorded down; chest x-ray, pulmonary function tests and HRCT were available in all cases. As the control group, we included data of 21 SLE, 44 AS, 27 OA, 16 gouty arthritis and 18 vasculitis patients.
Results: The frequencies of PPD positivity in RA (29.8%) and SLE (19%) patients were lower than in patients with AS (65.9%), gouty arthritis (68.8%) and OA (63%) (all p values < 0.01). PPD-positive RA patients were more frequently smokers (p = 0.005) and had a higher rate of RF seropositivity (p = 0.04) than PPD-negatives. PPD was less frequently positive in erosive RA disease (p = 0.033). Chest x-rays and HRCT abnormalities were detected in 41.8% and 62.7% of RA patients, respectively. Frequencies of chest x-ray and HRCT abnormalities in PPD-positive and PPD-negative patients were not different from each other (p > 0.05).
Conclusion: In our country in which tuberculosis is relatively frequent -contrary to the situation in AS patients- we observed a lower frequency of PPD positivity in RA and SLE patients compared to patients with other rheumatic diseases. We did not find any relationship between PPD positivity and the frequency of chest x-ray, HRCT abnormalities.
Similar articles
-
The results of purified protein derivative test in ankylosing spondylitis patients: clinical features, HRCT results and relationship with TNF-blocker usage.Rheumatol Int. 2008 Dec;29(2):179-83. doi: 10.1007/s00296-008-0665-x. Epub 2008 Aug 6. Rheumatol Int. 2008. PMID: 18682953
-
Relationship between high-resolution computed tomography findings and the Stoke index in patients with rheumatoid arthritis.Clin Rheumatol. 2005 Feb;24(1):14-7. doi: 10.1007/s10067-004-0954-z. Epub 2004 Aug 24. Clin Rheumatol. 2005. PMID: 15338447
-
[The evaluation of early pulmonary involvement with high resolution computerized tomography in asymptomatic and non-smoker patients with rheumatoid arthritis].Tuberk Toraks. 2009;57(1):14-21. Tuberk Toraks. 2009. PMID: 19533433 Turkish.
-
Correlations between high-resolution computed tomography of the chest and clinical function in patients with rheumatoid arthritis. Prospective study in 75 patients.Joint Bone Spine. 2005 Jan;72(1):41-7. doi: 10.1016/j.jbspin.2004.02.001. Joint Bone Spine. 2005. PMID: 15681247 Clinical Trial.
-
Pulmonary involvement in lifelong non-smoking patients with rheumatoid arthritis and ankylosing spondylitis without respiratory symptoms.Clin Rheumatol. 2006 Mar;25(2):213-8. doi: 10.1007/s10067-005-1158-x. Epub 2005 Aug 10. Clin Rheumatol. 2006. PMID: 16091838
Cited by
-
Evaluation of an interferon gamma assay in the diagnosis of latent tuberculosis infection in patients with rheumatoid arthritis.Rheumatol Int. 2009 Nov;30(1):57-62. doi: 10.1007/s00296-009-0910-y. Rheumatol Int. 2009. PMID: 19363612
-
Tuberculosis infection in rheumatic patients with infliximab therapy: experience with 157 patients.Rheumatol Int. 2012 Sep;32(9):2769-75. doi: 10.1007/s00296-011-2017-5. Epub 2011 Aug 7. Rheumatol Int. 2012. PMID: 21822912
-
Prevalence of latent tuberculosis before biotherapy initiation in rheumatoid arthritis and spondyloarthritis: data from the Moroccan biotherapy registry.Rheumatol Int. 2021 Sep;41(9):1625-1631. doi: 10.1007/s00296-021-04929-w. Epub 2021 Jun 26. Rheumatol Int. 2021. PMID: 34173843
-
Latent tuberculosis infection and tuberculosis in patients with rheumatic diseases treated with anti-tumor necrosis factor agents.Clin Rheumatol. 2017 Aug;36(8):1891-1896. doi: 10.1007/s10067-017-3714-6. Epub 2017 Jun 6. Clin Rheumatol. 2017. PMID: 28589321
-
Positiveness of purified protein derivatives in rheumatoid arthritis patients who are not receiving immunosuppressive therapy.Clin Rheumatol. 2009 Jan;28(1):53-7. doi: 10.1007/s10067-008-0982-1. Epub 2008 Aug 8. Clin Rheumatol. 2009. PMID: 18688673
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials